CT s emerging bioscience hubs key to industry s future job growth registercitizen.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from registercitizen.com Daily Mail and Mail on Sunday newspapers.
Stamford-based Cara Therapeutics Inc. (NASDAQ: CARA) is laying off part of its workforce in an effort to reduce operating costs while shifting its primary focus to developing a drug to treat notalgia paresthetica (NP), a neuropathic disorder for which here is no federally approved therapy.